246 related articles for article (PubMed ID: 37830558)
1. Overexpression of FRA1 (
Al-Khayyat W; Pirkkanen J; Dougherty J; Laframboise T; Dickinson N; Khaper N; Lees SJ; Mendonca MS; Boreham DR; Tai TC; Thome C; Tharmalingam S
Cells; 2023 Sep; 12(19):. PubMed ID: 37830558
[TBL] [Abstract][Full Text] [Related]
2. Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo.
Pirkkanen J; Tharmalingam S; Thome C; Sinex HC; Benjamin LV; Losch AC; Borgmann AJ; Dhaemers RM; Gordon C; Boreham DR; Mendonca MS
Radiat Res; 2023 Jul; 200(1):48-64. PubMed ID: 37141110
[TBL] [Abstract][Full Text] [Related]
3. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
4. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
5. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.
Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP
J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397
[TBL] [Abstract][Full Text] [Related]
6. The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.
Meise R; Tomicic MT; Kaina B; Christmann M
Biochim Biophys Acta; 2012 Jul; 1823(7):1199-207. PubMed ID: 22609303
[TBL] [Abstract][Full Text] [Related]
7. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
8. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
[TBL] [Abstract][Full Text] [Related]
9. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
10. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations.
Henken FE; De-Castro Arce J; Rösl F; Bosch L; Meijer CJ; Snijders PJ; Steenbergen RD
Cell Oncol (Dordr); 2012 Apr; 35(2):77-84. PubMed ID: 22271085
[TBL] [Abstract][Full Text] [Related]
11. FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction.
Niidome K; Taniguchi R; Yamazaki T; Tsuji M; Itoh K; Ishihara Y
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681621
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
13. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
Bergman MR; Cheng S; Honbo N; Piacentini L; Karliner JS; Lovett DH
Biochem J; 2003 Feb; 369(Pt 3):485-96. PubMed ID: 12371906
[TBL] [Abstract][Full Text] [Related]
14. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
15. Promoter specificity and biological activity of tethered AP-1 dimers.
Bakiri L; Matsuo K; Wisniewska M; Wagner EF; Yaniv M
Mol Cell Biol; 2002 Jul; 22(13):4952-64. PubMed ID: 12052899
[TBL] [Abstract][Full Text] [Related]
16. Naringenin targets ERK2 and suppresses UVB-induced photoaging.
Jung SK; Ha SJ; Jung CH; Kim YT; Lee HK; Kim MO; Lee MH; Mottamal M; Bode AM; Lee KW; Dong Z
J Cell Mol Med; 2016 May; 20(5):909-19. PubMed ID: 26861188
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of FRA1 protein in tumors.
Jiang X; Xie H; Dou Y; Yuan J; Zeng D; Xiao S
Mol Biol Rep; 2020 Jan; 47(1):737-752. PubMed ID: 31612408
[TBL] [Abstract][Full Text] [Related]
18. Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.
Diesch J; Sanij E; Gilan O; Love C; Tran H; Fleming NI; Ellul J; Amalia M; Haviv I; Pearson RB; Tulchinsky E; Mariadason JM; Sieber OM; Hannan RD; Dhillon AS
PLoS One; 2014; 9(3):e88950. PubMed ID: 24658684
[TBL] [Abstract][Full Text] [Related]
19. FOS-like antigen 1 is highly expressed in human psoriasis tissues and promotes the growth of HaCaT cells in vitro.
Zhu W; Li J; Su J; Li J; Li J; Deng B; Shi Q; Zhou Y; Chen X
Mol Med Rep; 2014 Nov; 10(5):2489-94. PubMed ID: 25175497
[TBL] [Abstract][Full Text] [Related]
20. Gene trap analysis of germ cell signaling to Sertoli cells: NGF-TrkA mediated induction of Fra1 and Fos by post-meiotic germ cells.
Vidal F; Lopez P; López-Fernández LA; Ranc F; Scimeca JC; Cuzin F; Rassoulzadegan M
J Cell Sci; 2001 Jan; 114(Pt 2):435-43. PubMed ID: 11148144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
